We are live on ! Find out more
TCBP

TC BioPharm (Holdings) plc American Depositary Shares
TCBP

Delisted

TCBP was delisted on the 21st of March, 2025.

Back to rankings

1 hedge funds and large institutions have $399K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
+$203K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
KC
1
Kepos Capital
New York
$264K +$203K +1 New
Citadel Advisors
2
Citadel Advisors
Florida
$32K – – –
TSS
3
Two Sigma Securities
New York
$30K – – –
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$25K – – –
VF
5
Virtu Financial
New York
$23K – – –
Jane Street
6
Jane Street
New York
$22K – – –
UBS Group
7
UBS Group
Switzerland
$2K – – –
Citigroup
8
Citigroup
New York
$1K – – –

TCBP Hedge Fund Activity: Q1 2022 in Review

1 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q1 2022, worth a combined $399K.

Buyers outnumbered sellers: 1 fund opened new TCBP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Kepos Capital, opening a new position worth an estimated $203K.

  • 1 institutional investor held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $399K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q1 2022.
  • 1 fund opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q1 2022 and 0 closed out, a net change of +1 holder.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q1 2022 was Kepos Capital, an estimated $203K added.

Based on aggregated 13F filings for Q1 2022.